Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
Clinical trial NCT03511859 · UNKNOWN
Trial details
- NCT number
- NCT03511859
- Sponsor
- CellMaxLife
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-16
- Primary completion
- 2018-12-31
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.